Endovascular Treatment in the Management of Mycotic Aortic Aneurysms

Mycotic aneurysms are rare, accounting for only 0.65% to 1.3% of all aortic aneurysms (1-3).

The natural history of mycotic aortic aneurysms is associated with significant mortality and

morbidity, which are due to delay in diagnosis, recurrent septic emboli, sudden expansion and

rupture with exsanguination. In addition any in situ prosthesis used to repair the aneurysm

may become secondarily infected, compounding the problem (Figs. 1A,B and 2).